Has Natalie Earl, MD received payments from drug or device companies?

Yes. Drug and device makers reported $13,660 in general payments to Natalie Earl, MD across 176 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Natalie Earl, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Natalie Earl, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Natalie Earl, MD

Otolaryngology · Chevy Chase, MDNPI 1346289394

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (46.8%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. Inspire Medical Systems, Inc. accounts for 67.6% of it on its own, with 18 other manufacturers making up the rest. 2025 is the largest year on record at $8,451, more than ten times the $427 reported in 2019. Among otolaryngology clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$13,660in general payments, 2019–2025

Across 176 payments — averaging $77.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Inspire Medical Systems, Inc.$9K
Aerin Medical Inc.$1K
GSK$756
Optinose US, Inc.$740
Regeneron Healthcare Solutions, Inc.$685
Sanofi$659
plus $556 from 13 others

What the payments were for

Consulting fees$1,42510%
Speaking & faculty fees$2,00015%
Travel & lodging$3,84128%
Food & beverage$6,39447%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Inspire Medical Systems, Inc.	31	$9,232
Aerin Medical Inc.	14	$1,032
GSK	29	$756
Optinose US, Inc.	35	$740
Regeneron Healthcare Solutions, Inc.	24	$685
Sanofi	20	$659
Acclarent, Inc	4	$178
Integra Lifesciences Corporation	2	$80
Merck	2	$44
Hikma Pharmaceuticals USA	2	$39
Kaleo, Inc.	2	$35
Harmony Biosciences LLC	1	$29
Arbor Pharmaceuticals, Inc.	2	$28
Phathom Pharmaceuticals, Inc.	3	$25
CSL Behring	1	$22
Lilly USA, LLC	1	$21
Stryker	1	$19
Smith+Nephew	1	$18
Amgen	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Inspire$6,574
Inspire Upper Airway Stimulation System$2,104
VIVAER STYLUS$544
RELIEVA SPINPLUS Balloon Sinuplasty System$244
Xhance$125
NUCALA$118
DUPIXENT$110

How this compares

$13,660 in reported general payments places this provider in the 95th percentile of 222 otolaryngology providers in Maryland.

See all otolaryngology providers in Maryland →

Medicare billing

Part B allowed, 2024

$119,430

Medicare patients

509

Services billed

975

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ipratropium Bromide	125	$5,527
Fluocinolone Acetonide Oil	23	$874
Azelastine Hcl	11	$614
Pantoprazole Sodium	14	$228
Doxycycline Hyclate	14	$116
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	15	$74
Prednisone	14	$47

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Chevy Chase

Seth OringherChevy Chase$429K
Philip SchoenfeldChevy Chase$5K
Jack WilliamsChevy Chase$4K
Jessica ShenChevy Chase$4K
Thomas WinklerChevy Chase$3K
Marc DubinBaltimore$350K
Douglas RehLutherville Timonium$231K
Patrick HaBaltimore$41K
Joshua LevyBethesda$40K
Andrew LaneBaltimore$34K

See the full list for Maryland →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →